FFA
ANIK icon

Farther Finance Advisors’s Anika Therapeutics ANIK Stock Holding History

Farther Finance Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16K Buy
213
+107
+101% +$1.59K ﹤0.01% 5003
2026
Q1 		$1.59K Buy
106
+25
+31% +$290 ﹤0.01% 4973
2025
Q4 		$778 Sell
81
-40
-33% -$383 ﹤0.01% 4964
2025
Q3 		$1.14K Sell
121
-1,655
-93% -$15.8K ﹤0.01% 4332
2025
Q2 		$18.8K Buy
1,776
+1,775
+177,500% +$22.4K ﹤0.01% 2717
2025
Q1 		$15 Sell
1
-6
-86% -$100 ﹤0.01% 4205
2024
Q4 		$115 Sell
7
-45
-87% -$888 ﹤0.01% 3762
2024
Q3 		$1.28K Sell
52
-25
-32% -$648 ﹤0.01% 3160
2024
Q2 		$1.99K Buy
77
+40
+108% +$1.04K ﹤0.01% 2799
2024
Q1 		$951 Hold
37
– – ﹤0.01% 2800
2023
Q4 		$838 Buy
+37
New +$766 ﹤0.01% 2799

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Farther Finance Advisors's ANIK Position: Q2 2026 in Review

Farther Finance Advisors increased its Anika Therapeutics (ANIK) stake by 101% in Q2 2026, buying an estimated $1.59K and bringing the position to 213 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #5003.

Farther Finance Advisors first reported a position in ANIK in Q4 2023 and has held it in 11 quarters since. The position peaked at $18.8K in Q2 2025. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Farther Finance Advisors held 213 shares of Anika Therapeutics worth $3.16K as of Q2 2026.
  • Farther Finance Advisors bought 107 Anika Therapeutics shares in Q2 2026, an estimated $1.59K.
  • Anika Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5003 holding.
  • Farther Finance Advisors first reported a position in Anika Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Anika Therapeutics position peaked at $18.8K in Q2 2025.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.